# Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study)

> **NCT01820078** · PHASE4 · TERMINATED · sponsor: **Fundación Renal Iñigo Alvarez De Toledo** · enrollment: 127 (actual)

## Conditions studied

- Chronic Kidney Disease, Unspecified

## Interventions

- **DRUG:** Experimental arm
- **OTHER:** Comparator Arm

## Key facts

- **NCT ID:** NCT01820078
- **Lead sponsor:** Fundación Renal Iñigo Alvarez De Toledo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-05
- **Primary completion:** 2013-09
- **Final completion:** 2013-12
- **Target enrollment:** 127 (ACTUAL)
- **Why stopped:** Recruitment not reached
- **Last updated:** 2013-11-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01820078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01820078, "Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01820078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*